HomeMarkets Markets Sanofi Agrees to Pay $2.9 Billion For Provention Bio By news March 13, 2023 0 171 FacebookTwitterPinterestWhatsApp Sanofi agreed to buy Provention Bio Inc. in a $2.9 billion deal intended to bolster the French drugmaker’s portfolio of diabetes medicines with a new …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected149,263FansLike396,312FollowersFollow2,670SubscribersSubscribe Latest Articles AI AI vs. Cybersecurity Stocks Markets 🔑 Mythos: The AI Master Key and the Global Security Tax Hot Items #PrinceHarming: 20 Short Quotes About Jared Kushner Markets American Princelings Markets Putin’s Puppet Project in Peril Markets I Am Mythos — Hear Me Roar AI Claude Mythos Is Everyone’s Problem Markets Friday’s Fragile “Peace” – Will it Last through the Weekend? Charts PSW’s Weekly Webinar: War and Fed Minutes (4/8/2026) Market News Peter Zeihan: What This Ceasefire Actually Means Markets How to Become a Millionaire by Investing $700 per Month – Part 44/360 Market News Trump’s ceasefire deal with Iran Market News Trump Made a Deal That Gives Him Nothing He Wanted Markets Wednesday Retracement – Trump and Iran Call “Time Out” on World War III Load more